➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
McKesson
AstraZeneca
Baxter
McKinsey
Mallinckrodt

Last Updated: July 14, 2020

DrugPatentWatch Database Preview

Cyproheptadine hydrochloride - Generic Drug Details

» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for cyproheptadine hydrochloride and what is the scope of freedom to operate?

Cyproheptadine hydrochloride is the generic ingredient in two branded drugs marketed by Actavis Mid Atlantic, Anda Repository, Elysium, Halsey, Lannett Co Inc, Lyne, Morton Grove, Naska, Pharm Assoc, Quagen, Merck, Am Therap, Apex Pharms Inc, Appco, Ascot, Beximco Pharms Usa, Boscogen, Chartwell Rx, Duramed Pharms Barr, Fosun Pharma, Heritage Pharma, Kv Pharm, Md Pharm, Mountain, Mylan, Novast Labs, Par Pharm, Pioneer Pharms, Pliva, Strides Pharma, Superpharm, Vitarine, Watson Labs, and Zydus Pharms, and is included in thirty-nine NDAs. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for cyproheptadine hydrochloride. Twenty-four suppliers are listed for this compound.

Recent Clinical Trials for cyproheptadine hydrochloride

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
ECSORPhase 2
Kinnov TherapeuticsPhase 2
All India Institute of Medical Sciences, BhubaneswarPhase 4

See all cyproheptadine hydrochloride clinical trials

Medical Subject Heading (MeSH) Categories for cyproheptadine hydrochloride

US Patents and Regulatory Information for cyproheptadine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs CYPROHEPTADINE HYDROCHLORIDE cyproheptadine hydrochloride TABLET;ORAL 086580-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Watson Labs CYPROHEPTADINE HYDROCHLORIDE cyproheptadine hydrochloride TABLET;ORAL 085245-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Ascot CYPROHEPTADINE HYDROCHLORIDE cyproheptadine hydrochloride TABLET;ORAL 087685-001 Oct 25, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Am Therap CYPROHEPTADINE HYDROCHLORIDE cyproheptadine hydrochloride TABLET;ORAL 088798-001 Feb 15, 1985 DISCN No No   Start Trial   Start Trial   Start Trial
Elysium CYPROHEPTADINE HYDROCHLORIDE cyproheptadine hydrochloride TABLET;ORAL 207555-001 Jan 31, 2017 AA RX No No   Start Trial   Start Trial   Start Trial
Pliva CYPROHEPTADINE HYDROCHLORIDE cyproheptadine hydrochloride TABLET;ORAL 088205-001 Jul 26, 1983 DISCN No No   Start Trial   Start Trial   Start Trial
Halsey CYPROHEPTADINE HYDROCHLORIDE cyproheptadine hydrochloride SYRUP;ORAL 089199-001 Jul 3, 1986 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
McKesson
AstraZeneca
Baxter
McKinsey
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.